You have 9 free searches left this month | for more free features.

refractory/relapsed acute myelogenous leukemia

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Acute Lymphocytic (ALL), Leukemia, Acute Myelogenous (AML), MDS Trial in Guangzhou (Chimeric antigen receptor T cells,

Recruiting
  • Leukemia, Acute Lymphocytic (ALL)
  • +2 more
  • Chimeric antigen receptor T cells
  • peptide specific dendritic cell
  • Guangzhou, Guangdong, China
    Zhujiang Hospital, Southern Medical University
Aug 1, 2021

Refractory Acute Myelogenous Leukemia, Relapsed Acute Myelogenous Leukemia Trial in Minneapolis (FATE-NK100)

Completed
  • Refractory Acute Myelogenous Leukemia
  • Relapsed Acute Myelogenous Leukemia
  • FATE-NK100
  • Minneapolis, Minnesota
    University of Minnesota, Masonic Cancer Center
Mar 10, 2021

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blasts 5 Percent or More of Bone Marrow Nucleated Cells,

Terminated
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +10 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 17, 2021

Acute Myelogenous Leukemia, MDS, Mixed Phenotype Acute Leukemia Trial (Fludarabine, Cytarabine, Uproleselan)

Not yet recruiting
  • Acute Myelogenous Leukemia
  • +2 more
  • (no location specified)
Mar 3, 2022

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia, in Relapse
  • anti Tim-3/CD123 CAR-T cell therapy
  • Xuzhou, Jiangsu, China
    Kailin Xu
Nov 4, 2023

Acute Myelogenous Leukemia Trial in Sacramento (Bortezomib, Doxil)

Completed
  • Acute Myelogenous Leukemia
  • Sacramento, California
    University of California Comprehensive Cancer Center
Feb 4, 2021

Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission Trial in São Paulo (Bortezomib)

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • Acute Lymphoblastic Leukemia With Failed Remission
  • São Paulo, SP, Brazil
    Instituto do Cancer do Estado de Sao Paulo
Sep 12, 2023

Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • CD123 targeted CAR-NK cells
  • Taiyuan, Shanxi, China
    Shanxi Bethune Hospital
Aug 28, 2023

Acute Myeloid Leukemia Trial in Beijing (Ven+CAG)

Recruiting
  • Acute Myeloid Leukemia
  • Beijing, Beijing, China
    Peking University People's Hospital
Jun 23, 2023

Relapsed/Refractory Acute Myeloid Leukemia Trial in Hangzhou (B7-H3 target, CAR gene modified gdT cell injection)

Recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia
  • B7-H3 target, CAR gene modified gdT cell injection
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University School of Med
Feb 15, 2023

Acute Myelogenous Leukemia Trial in Canada, United States (TAK-659)

Terminated
  • Acute Myelogenous Leukemia
  • Birmingham, Alabama
  • +16 more
Apr 14, 2021

B-cell Acute Lymphoblastic Leukemia Trial (HY004, Cyclophosphamide, Fludarabine Phosphate)

Not yet recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • HY004
  • +2 more
  • (no location specified)
Aug 18, 2023

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • (no location specified)
Nov 9, 2023

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Recruiting
  • Recurrent Childhood Acute Myeloid Leukemia
  • +17 more
    • Miami, Florida
      Nicklaus Children's Hospital
    May 13, 2023

    Relapsed or Refractory Acute Myeloid Leukemia Trial in Taiyuan (Selinexor, Homoharringtonine, Daunorubicin)

    Recruiting
    • Relapsed or Refractory Acute Myeloid Leukemia
    • Taiyuan, Shanxi, China
      Tao Wang
    Feb 9, 2023

    B-cell Acute Lymphoblastic Leukemia Trial in Hefei (QH103 Cell Injection, Fludarabine, Cyclophosphamide)

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • QH103 Cell Injection
    • +2 more
    • Hefei, Anhui, China
      Anhui Provincial Hospital
    Sep 21, 2023

    AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

    Not yet recruiting
    • AML
    • +11 more
    • (no location specified)
    Aug 14, 2023

    Tumors, Hematologic Tumors, Hematologic Diseases Trial in Xuzhou (RD13-02 cell infusion)

    Recruiting
    • Neoplasms
    • +2 more
    • RD13-02 cell infusion
    • Xuzhou, Jiangsu, China
      Affiliated hospital of Xuzhou medical college
    Jun 7, 2023

    PET-CT Imaging in Relapsed/Refractory Acute Leukemias

    Not yet recruiting
    • B Cell
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 4, 2023

      Relapsed/Refractory Acute Myeloid Leukemia Trial in Hefei (gdT cell injection targeting B7-H3 chimeric antigen receptor)

      Recruiting
      • Relapsed/Refractory Acute Myeloid Leukemia
      • gdT cell injection targeting B7-H3 chimeric antigen receptor
      • Hefei, Anhui, China
        PersonGen Anke Cellular Therapeutice Co., Ltd.
      Jan 31, 2023

      Relapsed/Refractory AML Trial in Suzhou (Selinexor, Homoharringtonine, Cytarabine)

      Not yet recruiting
      • Relapsed/Refractory AML
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Mar 28, 2023

      B-cell Acute Lymphoblastic Leukemia Trial (CD19-CAR_Lenti_ALLO)

      Not yet recruiting
      • B-cell Acute Lymphoblastic Leukemia
      • (no location specified)
      Oct 10, 2023

      T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

      Not yet recruiting
      • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
      • CD7-CART01
      • (no location specified)
      Sep 26, 2023

      Acute Myeloid Leukemia (Relapsed/Refractory) Trial in Suzhou (Selinexor, Chidamide)

      Recruiting
      • Acute Myeloid Leukemia (Relapsed/Refractory)
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Jul 16, 2023

      Acute Myeloid Leukemia Trial in Minneapolis (ALT-803)

      Completed
      • Acute Myeloid Leukemia
      • ALT-803
      • Minneapolis, Minnesota
        Masonic Cancer Center at University of Minnesota
      Oct 30, 2020